JOHN HILL: Open Payments
NPI 1558380444 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 83 payments from 19 companies in 2025. Trend: 2023 $2,564 · 2024 $2,055 · 2025 $1,787
Food & beverage: $1,787
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $509 |
| Novo Nordisk Inc | 15 | $373 |
| ABBVIE INC. | 10 | $177 |
| Novartis Pharmaceuticals Corporation | 11 | $172 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 6 | $95 |
| Lilly USA, LLC | 4 | $74 |
| PFIZER INC. | 2 | $48 |
| Corcept Therapeutics | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
Products named: Ozempic, REPATHA, LEQVIO, OTEZLA, EVENITY, MOUNJARO, QULIPTA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
